SEC Form 4 · accession 0001144204-15-017046
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sunil Bhonsle
Officer — President · Director
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.60 | Mar 16, 2015 | A | 240,000 | D | — | Mar 16, 2025 | Common Stock | 240,000 | 240,000 | D |
Explanation of responses
- F150% of the options have vested on the grant date and the balance shall vest on the first anniversary of the grant date